People

The People

Governance grade: C+. Target's process and committee architecture look textbook — annual elections, majority voting, independent committees, robust ownership guidelines — but the structural choice to keep outgoing CEO Brian Cornell as Executive Chair with operational oversight while promoting his lieutenant Michael Fiddelke to CEO has handed activists a clean talking point. With the stock down 28% in 2025, a 753-to-1 CEO pay ratio, an activist (Toms Capital) on the register, and ~$500M of public-pension investors backing an independent-chair proposal at the June 2026 AGM, governance is a real source of investment risk, not just hygiene.

Governance Grade: C+ — Independent chair denied; insider CEO promoted; pay rising as TSR declined. Why the skin-in-the-game score is 6: Strong guidelines, weak actual stake.

The People Running This Company

The NEO roster turned over heavily in FY2025: Cornell to Executive Chair, COO Fiddelke to CEO, CCO (Gomez) and CLO (Tu) departed, longtime insider (Roath) elevated to COO in a Feb 2026 reshuffle. The bench remains thin and dominated by 20-year veterans, not an outside reset.

Role	Name	Years at Target
CEO	Michael J. Fiddelke	22
Executive Chair	Brian C. Cornell	12 (as CEO from 2014–2026)
CFO	Jim Lee	1

Fiddelke (CEO). Promoted from the COO role he held during the period that produced four straight years of stagnant sales and a 50% peak-to-trough share price decline. Investors initially "panned" the choice (Reuters, Aug 2025) and the stock slumped on the announcement. He has since cut 1,800 corporate roles, committed an incremental $1B to 2026 capex, and re-shuffled the C-suite — moves analysts have called "deliberate," but which still rely on him outgrowing the pattern set during his own COO tenure. Total FY25 comp $9.6M; owns 66,928 shares (~$8M).

Cornell (Executive Chair). The retention of the outgoing CEO as Executive Chair — not non-executive Chair — with a fresh $6M RSU grant, a 200%-of-salary STIP target, and personal use of company aircraft for security reasons ($373K in incremental cost) is the central governance flashpoint. Target's own disclosure says he is "anticipated to serve as Executive Chair or a special advisor until March 13, 2027." His fingerprints will remain on strategy through the entire critical first year of Fiddelke's tenure.

Lee (CFO, 14 months in seat). Joined Sep 2024 from PepsiCo Beverages North America with an $8.5M sign-on equity grant and $2.3M cash. The hire is a positive signal — first non-Target outsider in the senior finance seat in years — but he owns just 8,871 shares directly, which is well below the 3x-base-salary ownership guideline and gives him five fiscal years to comply.

The bench problem. Of the seven leadership-team members publicly disclosed, five are 20-year-plus Target lifers. There is no externally-recruited COO, CMO, or Chief Strategy Officer. Outside hires of Lee (CFO) and Zabel (Corp Affairs) are recent and reactive.

What They Get Paid

Cornell drew $21.8M in FY2025 and Fiddelke $9.6M — both year-on-year increases against net sales −1.7%, operating income −8.1%, adjusted EPS −14.5%, and TSR ranked 17 of 19 retail peers (relative-TSR PBRSU paid out 75%, the floor). The pay-for-performance machinery partially worked — STIP paid 44.6% of goal — but stock awards rose because Cornell's market-data-anchored grant size went up.

The TSR ranking is the headline. Three-year relative TSR landed 17 of 19 retail peers — second-from-bottom — yet PBRSUs paid out the 75% floor rather than 0% because the plan caps downside. Combined with EPS-CAGR ranking 6/20 (paying 154%), the LTI program paid ~89% on average, not the 0–25% an absolute reading of TSR would suggest. By design (relative outperformance can mask absolute decline), but it is the structural reason CEO pay rose while shareholders lost a fifth of their capital.

Cornell's FY2026 letter agreement carries forward $1.12M base, 200%-of-salary STIP target, and a $6M RSU grant vesting over two years. He waived ICP severance — a small concession.

Pay ratio (FY24): 753-to-1. AFL-CIO Paywatch flags Cornell's $20.4M FY2024 total at 753 times Target's median employee — high even within retail.

Are They Aligned?

This is where the letter and the spirit of governance diverge. On paper, Target has 7x-base-salary CEO ownership guidelines (Cornell sits at 34x), strict anti-hedging/anti-pledging policies, double-trigger change-in-control vesting, no excise tax gross-ups, no dividends on unvested awards, and a clawback policy. In practice, all directors and executives as a group own 0.13% of the company (595,877 shares of 454.2M outstanding), insider activity has been one-way out for two years, and the activist on the register is now its largest "active" voice.

Insider buying vs. selling. Zero open-market buys in 24 months. All Form 4 acquisitions are option/RSU vests. Cornell sold $11.5M in two open-market trades (45,000 shares @ $96.18 May 2025; 50,000 @ $121.76 March 2026). The March 2026 sale at a one-year high was telegraphed as tax-planning, but the optics are unhelpful when the activist pitch is "leadership has lost confidence in the turnaround."

Dilution and the 2026 Long-Term Incentive Plan amendment. The board is asking shareholders at the June 2026 AGM to add 15.5M shares to the 2020 LTIP — a roughly 3.4% incremental share authorization on top of the 9M already outstanding. The 3-year burn rate of 0.71% is reasonable, but the request comes when (a) management is being scrutinized for pay vs. performance, and (b) the company has otherwise been buying back stock (capital allocation through buybacks at peak prices, then asking for fresh equity dilution at trough prices, is the criticism activists typically lead with).

Capital allocation behavior. The company is a Dividend King with an unbroken raise streak; the FY26 dividend is $1.14/share. Buybacks have been opportunistic but the "buy high, dilute low" critique applies — share count fell from ~462M (FY23) to ~454M (FY26) but was at substantially higher prices. The $1B incremental capex plan announced for FY2026 is a clear pivot from buyback-heavy capital return to operational reinvestment.

Related-party items: small but real.

Item	Counterparty	Annual amount	% of revenue	Independence determination
Director Knauss's son	Wholesale supplier	$15M (FY25, down from $60M FY18)	<0.02%	Knauss "independent"
Director Leahy's company	CDW Corp (IT supplier)	Disclosed but not quantified	"Immaterial"	Leahy still "Lead Independent Director"

Both fall well below NYSE materiality thresholds, but Leahy's role as Lead Independent Director while running a vendor is the kind of detail proxy advisors flag. CDW is also Target's primary IT solutions vendor for stores — a role Target's tech-acceleration strategy will scale.

Skin-in-the-game score: 6 of 10. Cornell's 34× ownership multiple is genuine and ownership guidelines have been met by eligible executives. But the absolute insider stake (<1%) is low for a $57B retailer, two-year buying activity is zero, and the activist on the register has more conviction than management.

Board Quality

Twelve nominees for the 2026 AGM, ten of whom are independent. Three long-serving directors (Baker — 13 yrs, Knauss — 11 yrs, Puma — 4 yrs) are leaving; two new merchandising-heavy directors (Hoke from Nike, Bratspies from HanesBrands/Walmart) joined Q1 2026 specifically to support Fiddelke's reset. The board is technically refreshed, but the "long-tenure dependency on Cornell" cluster (Cornell himself, Lozano-12 yrs, Edwards-11 yrs, Stockton-8 yrs) still represents the institutional weight on key committees.

The bright spots.

• Five Audit Committee members all qualify as "audit committee financial experts" under SEC rules — unusually deep.
• Auditor (EY since 1931) gets a fresh lead engagement partner every five years; FY27 partner rotation was scheduled in early 2026.
• All four committees consist exclusively of independent directors.
• Annual elections, majority voting, 3%/3-yr proxy access, 10% special meeting threshold — all leading practices.
• 92.2% Say-on-Pay support in 2025, after 95%+ in prior years.

The structural weaknesses.

• No independent chair despite operational underperformance and an activist demand. Cornell has been on the board since 2014 and ran the company throughout the period of share-price weakness now being relitigated.
• Independent-director skills are weighted towards healthcare and CPG. Retail-industry experience is held by only 5 of 10 (Bratspies, Edwards, Cornell himself, Hoke, plus Rice with consumer-pharmacy retail). The 2026 additions of Hoke (Nike Innovation) and Bratspies (HanesBrands/Walmart) are visibly an attempt to fix this — and shareholder feedback in the proxy ("brand and reputation management" was a top engagement topic) suggests the gap was understood internally.
• Director busyness: Rice serves on 4 public boards (Bristol-Myers, Carlyle, Disney, Target). Lozano serves on Apple, Bank of America, and Target. Both meet Target's 4-board cap, but four-board service for a director also chairing or sitting on heavy committees deserves monitoring.
• Lead Independent Director rotation: Lozano served as LID from 2018 through Jan 2025 — at the upper end of Target's own four-to-six-year guideline — before Leahy took over.

Compliance and audit detail. No financial restatements, no SEC enforcement actions, no material weaknesses disclosed. Audit fees of $8.82M for FY25 ($7.76M FY24) are reasonable for a $107B-revenue retailer; tax fees ($1.33M) modestly elevated but within tolerance. One related-party transaction ratified, properly disclosed.

The Verdict

Grade: C+ (potential to upgrade to B if the June 2026 vote forces structural change; potential to downgrade to C if the activist exits without governance concessions).

Governance Grade: C+ — Strong process, structural problem. Bottom line: independent-chair vote in June 2026 is the swing factor.

The strongest positives.

• Dividend King with 50+ years of consecutive raises, signaling capital-discipline culture.
• 100% of LTI is performance-based; STIP paid 44.6% in FY25 — pay-for-performance machinery functions for short-term metrics.
• Stock ownership guidelines (7x CEO base salary, 5x director cash retainer) are enforced and met.
• All committees are 100% independent; five audit-committee members are SEC financial experts.
• Clean compliance record — no restatements, no material weaknesses, no SEC enforcement.
• Leadership refresh in Q1 2026 (Hoke, Bratspies on board; Roath as COO; Sylvester as CMO) addresses the previously thin merchandising bench.

The real concerns.

• Cornell remains Executive Chair with explicit operational oversight through ~March 2027, undercutting the "fresh start" narrative for Fiddelke.
• CEO promoted from inside after presiding (as COO) over the period of underperformance now being criticized.
• 753:1 CEO pay ratio; CEO/Chair total comp rose three years in a row while net sales, EPS, ROIC and three-year relative TSR all fell — relative-TSR PBRSU floor (75%) shielded executives from a 17/19 peer ranking.
• Insider open-market buying: zero in 24 months; CEO/Chair sold $11.5M.
• Activist (Toms Capital, 0.6%) and ~$500M of public-pension investors backing independent-chair proposal at June 2026 AGM — six prior similar proposals failed but momentum is highest since 2014's 45.8%.
• LTIP amendment seeking 15.5M additional shares (~3.4% incremental dilution capacity) is being asked of an unhappy shareholder base.
• Lead Independent Director (Leahy) is CEO of a vendor (CDW); deemed immaterial but optically suboptimal.

The single change that would most likely upgrade or downgrade the score.

• Upgrade to B / B+: Cornell relinquishes Executive Chair earlier than March 2027 and the board appoints an independent (non-employee, non-recently-employee) chair. A material vote (≥40%) in favor of the independent-chair proposal at the June 2026 AGM would also be a catalyst, as would TCIM's stake passing 1% with constructive board engagement.
• Downgrade to C: TCIM exits without concessions; the independent-chair proposal collapses to <30% support; a second restated-LTIP request follows in 2027; or insider sales accelerate above the FY25 run-rate.